Free Trial

EUROFINS SCIENT (OTCMKTS:ERFSF) Shares Gap Down - Here's What Happened

Eurofins Scient logo with Medical background

Key Points

  • Eurofins Scient's shares gapped down from a previous close of $75.72 to $73.83 at market opening, with trading volume reported at 200 shares.
  • Wall Street analysts maintain a cautious outlook, with Citigroup reaffirming a "neutral" rating and an average stock rating of "Hold."
  • The company's debt-to-equity ratio stands at 0.77, with a current ratio of 1.26 and a quick ratio of 1.19.
  • Five stocks we like better than Eurofins Scient.

Shares of EUROFINS SCIENT (OTCMKTS:ERFSF - Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $75.72, but opened at $73.83. EUROFINS SCIENT shares last traded at $73.83, with a volume of 200 shares traded.

Analyst Upgrades and Downgrades

Separately, Citigroup reaffirmed a "neutral" rating on shares of EUROFINS SCIENT in a research report on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating and five have issued a Hold rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold".

Read Our Latest Research Report on EUROFINS SCIENT

EUROFINS SCIENT Stock Performance

The stock's fifty day moving average is $76.18 and its two-hundred day moving average is $67.01. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.19 and a current ratio of 1.26.

EUROFINS SCIENT Company Profile

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

Featured Articles

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.